Tao Pan to CRISPR-Cas Systems
This is a "connection" page, showing publications Tao Pan has written about CRISPR-Cas Systems.
Connection Strength
0.043
-
Genetic correction of concurrent a- and ß-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology. Stem Cell Res Ther. 2022 03 07; 13(1):102.
Score: 0.043